Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase NA 1

Status

Completed 7Active not recruiting 5Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Breast Neoplasms 8Prostatic Neoplasms 7Carcinoma, Non-Small-Cell Lung 3Urogenital Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Prostate Adenocarcinoma 1Neoplasms, Radiation-Induced 1Melanoma 1Lymphatic Metastasis 1Lung Neoplasms 1Locally Advanced Lung Carcinoma 1Glioma 1Genital Neoplasms, Male 1Financial Stress 1Diffuse Intrinsic Pontine Glioma 1Deception 1Carcinoma, Merkel Cell 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Cancer 1

Interventions

Docetaxel 158Prednisone 131Leuprolide 95bicalutamide 86enzalutamide 83Radiotherapy 80Goserelin 80Abiraterone Acetate 76acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54Magnetic Resonance Spectroscopy 46Zoledronic Acid 44gallium 68 PSMA-11 37Flutamide 34abiraterone 32Estramustine 32radium Ra 223 dichloride 30apalutamide 27Surveys and Questionnaires 26Gonadotropin-Releasing Hormone 26Androgen Antagonists 25cabazitaxel 24Radiosurgery 24Dutasteride 22sipuleucel-T 21Prednisolone 21Triptorelin Pamoate 20Paclitaxel 20luprolide acetate gel depot 19Radiation 19Exercise 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms × Radiation Dose Hypofractionation × Clear all
NCT03570827 2026-05-26

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Mayo Clinic

Phase 2 Completed
53 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT00809991 2026-02-18

Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
91 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

NCT02311049 2022-12-29

Hypofractionated Radiotherapy for Prostate Cancer

University Hospital, Ghent

Phase 2 Completed
346 enrolled
Genitourinary

Prostatic Neoplasms

NCT01921803 2022-12-22

Hypofraction

University Hospital, Ghent

Phase 2 Completed
346 enrolled
Genitourinary

Prostatic Neoplasms

NCT02319239 2020-10-28

ESKO

Tampere University Hospital

Phase NA Completed
80 enrolled
Genitourinary

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

NCT01146340 2019-10-04

PHART6

Sunnybrook Health Sciences Centre

Phase 1/2 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT00129025 2011-10-10

Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer

AHS Cancer Control Alberta

Phase 1/2 Completed
35 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡